We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Color Cytometer Analyzes Pathology Specimens

By Biotechdaily staff writers
Posted on 22 Feb 2006
A new fluoro-chromatic imaging cytometer is designed for the automated quantitative analysis of research pathology specimens.

The iColor cytometer not only capitalizes on the availability of new reagent technologies to identify and visualize specific molecular targets in tissue specimens but couples these advances with a quantitative analysis of complex molecular processes at the individual cell level. More...
The iColor does this while supporting every component of the pathologist's traditional routine, including excellent digital images, the ability to analyze standard histopathology specimens, and the option to interrupt the automated process at any time if expert pathologist input is required.

The system employs three lasers that simultaneously measure both fluorescent light emitted by specimens stained with fluorescent dyes and the light absorbance resulting from the application of chromatic stains to the same specimens. iColor enables the pathologist to render laser scan images that are "true color,” similar to those obtained with brightfield microscopy.

iColor was developed by CompuCyte Corp. (Cambridge, MA, USA). The company has collaborated with Asterand plc (Royston, UK) to validate the application of iColor in numerous pathology applications.

"We are particularly interested in the rapid progress being made in understanding the molecular mechanisms of various cancers, coupled with the introduction of novel therapeutic agents that target these mechanisms,” noted Dr. Elena Holden, president and CEO of CompuCyte. "Monitoring drug action at the molecular level has become an increasingly important component of clinical trials, and iColor is proving to be an effective means of accomplishing this.”



Related Links:
CompuCyte

New
Gold Member
Automatic Hematology Analyzer
CF9600
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
New
Thyroid Test
Anti-Thyroid EIA Test
New
Rapid Sepsis Test
SeptiCyte RAPID
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more

Molecular Diagnostics

view channel
Image: The new approach focuses on CpG DNA methylation, a chemical modification of cytosine and guanine bases, using tumor samples to develop a computational model that distinguishes among 21 cancer types (photo credet: 123RF)

Machine Learning Model Uses DNA Methylation to Predict Tumor Origin in Cancers of Unknown Primary

Cancers of unknown primary (CUP) are metastatic malignancies in which the primary site cannot be identified, complicating treatment selection. Many patients consequently receive broad, nonspecific chemotherapy... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.